Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir

We examined the prevalence of cleavage site mutations, both within and outside the gag region, in 28 protease inhibitor (PI) cross-resistant patients treated with indinavir, ritonavir, and/or saquinavir compared to control patients treated with reverse transcriptase inhibitors. Three human immunodef...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Côté, Hélène C. F., Brumme, Zabrina L., Harrigan, P. Richard
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2001
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC113954/
https://ncbi.nlm.nih.gov/pubmed/11134271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.2.589-594.2001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires